GSA Capital Partners LLP Grows Stock Holdings in Simulations Plus, Inc. $SLP

GSA Capital Partners LLP boosted its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 167.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 62,322 shares of the technology company’s stock after acquiring an additional 39,059 shares during the period. GSA Capital Partners LLP’s holdings in Simulations Plus were worth $1,136,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Tudor Investment Corp ET AL purchased a new stake in Simulations Plus during the third quarter valued at $1,810,000. Royce & Associates LP raised its stake in Simulations Plus by 31.6% during the third quarter. Royce & Associates LP now owns 348,758 shares of the technology company’s stock valued at $5,256,000 after purchasing an additional 83,758 shares in the last quarter. Nicholas Company Inc. raised its stake in Simulations Plus by 42.9% during the fourth quarter. Nicholas Company Inc. now owns 262,712 shares of the technology company’s stock valued at $4,789,000 after purchasing an additional 78,854 shares in the last quarter. Herald Investment Management Ltd purchased a new stake in Simulations Plus during the third quarter valued at $3,016,000. Finally, JPMorgan Chase & Co. raised its stake in Simulations Plus by 154.7% during the third quarter. JPMorgan Chase & Co. now owns 167,646 shares of the technology company’s stock valued at $2,526,000 after purchasing an additional 101,822 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. TD Cowen decreased their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 10th. Zacks Research downgraded shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 2nd. Finally, Wall Street Zen raised shares of Simulations Plus from a “hold” rating to a “buy” rating in a research note on Saturday, May 16th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $24.40.

Simulations Plus Trading Up 4.4%

Shares of SLP opened at $15.11 on Friday. Simulations Plus, Inc. has a twelve month low of $11.09 and a twelve month high of $34.01. The company has a market cap of $305.22 million, a P/E ratio of -4.83 and a beta of 1.28. The company’s fifty day simple moving average is $13.40 and its 200-day simple moving average is $15.66.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.08. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. The business had revenue of $24.29 million for the quarter, compared to the consensus estimate of $21.66 million. Analysts predict that Simulations Plus, Inc. will post 0.85 earnings per share for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.